The majority of metachronous CIN1 and CIN3 lesions are caused by different human papillomavirus genotypes, indicating that the presence of CIN1 seems not to determine the risk for subsequent detection of CIN3

被引:5
|
作者
Litjens, Rogier J. N. T. M. [1 ,2 ]
Van de Vijver, Koen K. [3 ]
Hopman, Anton H. N. [1 ]
Ummelen, Monique I. [1 ]
Speel, Ernst-Jan M. [3 ]
Sastrowijoto, Suprapto H. [4 ]
Van Gorp, Toon [2 ]
Slangen, Brigitte F. M. [2 ]
Kruitwagen, Roy F. P. M. [2 ]
Kruse, Arnold-Jan [2 ]
机构
[1] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Mol Cell Biol, NL-6202AZ Maastricht, Netherlands
[2] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Obstet & Gynaecol, NL-6202 AZ Maastricht, Netherlands
[3] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Pathol, NL-6202AZ Maastricht, Netherlands
[4] Orbis Med Ctr, Dept Pathol, NL-6130MB Sittard, Netherlands
关键词
Progression; CIN; Natural history; HPV genotyping; Cervical cancer; CERVICAL INTRAEPITHELIAL NEOPLASIA; NATURAL-HISTORY; INFECTION; IDENTIFICATION; DIAGNOSIS; ENABLES; GRADE-3; BIOPSY; COHORT; WOMEN;
D O I
10.1016/j.humpath.2013.10.014
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Cervical intraepithelial neoplasia (CIN) is historically viewed as a progressive biologic continuum leading to cervical cancer. However, it has been questioned whether CIN1 lesions ever. progress. To this end, we evaluated the number of patients with a CIN3 and a previous CIN1 diagnosis. Subsequently, metachronous CIN1 and CIN3 lesions were reviewed and human papillomavirus (HPV) genotyping was performed to evaluate whether CIN1 lesions do progress. The medical records of 1819 patients diagnosed with a CIN3 lesion were retrieved from the archives, and prior Pap smear surveillance was available for 1474 patients. Forty-four CIN3 patients (3.0%) had a previous CIN1 lesion, and review of the biopsies confirmed 43 out of 44 CIN3 lesions and 37 out of 44 CIN1 lesions (78%). Three cases were not available for analysis, and in another three cases the quality of the isolated DNA was insufficient for further analysis. Out of the 30 remaining patients, 19 patients had different HPV genotypes in their CIN1 and CIN3 lesion. The cytological diagnosis leading to the CIN1 biopsy showed high-grade squamous intraepithelial lesion in 11 out of 19 patients with a different HPV genotype in the metachronous CIN1 and CIN3 lesions. High-grade squamous intraepithelial lesion was detected in 7 out of 11 patients with the same BIN genotype. Our results show that CIN3 lesions are rarely preceded by a CIN1 lesion. The majority of metachronous CIN1 and CIN3 lesions are caused by different HPV genotypes, indicating that the presence of CIN1 seems not to determine the risk for subsequent detection of CIN3. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:221 / 226
页数:6
相关论文
共 40 条
  • [1] THE MAJORITY OF METACHRONOUS CIN1 AND CIN3 LESIONS ARE CAUSED BY DIFFERENT HPV GENOTYPES, INDICATING THAT ACTUAL PROGRESSION OF CIN1 IS A RARE EVENT
    Litjens, R.
    Van de Vijver, K. K.
    Hopman, A. H. N.
    Ummelen, M. I.
    Speel, E. J. M.
    Sastrowijoto, S. H.
    Van Gorp, T.
    Kruitwagen, R. F. P. M.
    Slangen, B. F. M.
    Kruse, A. J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [2] Co-factors of high-risk human papillomavirus infections display unique profiles in incident CIN1, CIN2 and CIN3
    Syrjanen, K.
    Shabalova, I.
    Naud, P.
    Derchain, S.
    Sarian, L.
    Kozachenko, V.
    Zakharchenko, S.
    Roteli-Martins, C.
    Nerovjna, R.
    Longatto-Filho, A.
    Kljukina, L.
    Tatti, S.
    Branovskaja, M.
    Branca, M.
    Grunjberga, V.
    Erzen, M.
    Juschenko, A.
    Hammes, L. Serpa
    Costa, S.
    Podistov, J.
    Syrjanen, S.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2011, 22 (05) : 263 - 272
  • [3] Covariates of high-risk human papillomavirus (HPV) infections are distinct for incident CIN1, CIN2 and CIN3 as disclosed by competing-risks regression models
    Syrjanen, K.
    Shabalova, I.
    Sarian, L.
    Naud, P.
    Longatto-Filho, A.
    Derchain, S.
    Kozachenko, V.
    Zakharchenko, S.
    Roteli-Martins, C.
    Nerovjna, R.
    Kljukina, L.
    Tatti, S.
    Branovskaja, M.
    Branca, M.
    Grunjberga, V.
    Erzen, M.
    Juschenko, A.
    Hammes, L. Serpa
    Podistov, J.
    Costa, S.
    Syrjanen, S.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2012, 33 (01) : 5 - 14
  • [4] Viral load of human papillomavirus and risk of CIN3 or cervical cancer
    Lorincz, AT
    Castle, PE
    Sherman, ME
    Scott, DR
    Glass, AG
    Wacholder, S
    Rush, BB
    Gravitt, PE
    Schussler, JE
    Schiffman, M
    LANCET, 2002, 360 (9328): : 228 - 229
  • [5] Human papillomavirus vaccine to prevent CIN3 or worse (CIN3+): A nationwide case-control study in Japan
    Ikeda, Sayaka
    Ueda, Yutaka
    Yagi, Asami
    Mizushima, Taichi
    Sukegawa, Akiko
    Kudoh, Risa
    Yamaguchi, Manako
    Kurosawa, Megumi
    Miyagi, Etsuko
    Sekine, Masayuki
    Enomoto, Takayuki
    CANCER SCIENCE, 2025, 116 (01) : 226 - 232
  • [6] Prevalence and genotypes of human papilloma virus infection in CIN3 in Beijing, China
    Zhao, Xuan-Yu
    Kong, Wei-Min
    Jiao, Si-Meng
    Song, Dan
    Chen, Jiao
    Shang, Ruo-Tian
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (03) : 1978 - 1984
  • [7] Evaluating the epidemiology and morbidity burden associated with human papillomavirus in IsraelAccounting for CIN1 and genital warts in addition to CIN2/3 and cervical cancer
    Oren Shavit
    Raanan Raz
    Michal Stein
    Gabriel Chodick
    Eduardo Schejter
    Yehuda Ben-David
    Raanan Cohen
    Daphna Arbel
    Varda Shalev
    Applied Health Economics and Health Policy, 2012, 10 (2) : 87 - 97
  • [8] Evaluating the Epidemiology and Morbidity Burden Associated with Human Papillomavirus in Israel Accounting for CIN1 and Genital Warts in Addition to CIN2/3 and Cervical Cancer
    Shavit, Oren
    Raz, Raanan
    Stein, Michal
    Chodick, Gabriel
    Schejter, Eduardo
    Ben-David, Yehuda
    Cohen, Raanan
    Arbel, Daphna
    Shalev, Varda
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2012, 10 (02) : 87 - 97
  • [9] The role of human papillomavirus test after conization for CIN3 in predicting residual disease
    Shirakuni, Akari
    Yoshida, Ai
    Takeda, Akiko
    Sugimoto, Makoto
    Takeuchi, Kyousuke
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2016, 118 : 128 - 128
  • [10] The Detection of High Risk Types of HPV Using Cervista® HPV HR and PGMY PCR In Subjects With CIN2 and CIN3 Histology
    King, J. J.
    Day, S. P.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (06): : 892 - 892